{"database": "lobbying", "table": "lobbying_activities", "is_view": false, "human_description_en": "where filing_period = \"third_quarter\", filing_year = 2019 and issue_code = \"MMM\" sorted by filing_year descending", "rows": [[2336095, "42ef3b00-9991-46e3-a11c-74950a586c74", "3T", "THE PETRIZZO GROUP, INC.", 305932, "SEATTLE CANCER CARE ALLIANCE", 2019, "third_quarter", "MMM", "Advocated on behalf of current law designation and payment for dedicated cancer centers. Advocated for appropriate CAR-T reimbursements. Advocated for advanced cancer care access.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 1, "2019-08-23T12:04:42.920000-04:00"], [2336241, "864e15d4-7725-40b5-95e4-f606bf1db4d7", "3T", "MR. THEODORE (TED) JONES", 20926, "OCHSNER HEALTH SYSTEM, INC.", 2019, "third_quarter", "MMM", "Healthcare, Medicare and Medicaid", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 1, "2019-08-30T12:00:42.860000-04:00"], [2336999, "af335c88-2499-4dd7-becd-627265bcd197", "3T", "RED MAPLE CONSULTING, LLC", 400382761, "POTOMAC PARTNERS DC (ON BEHALF OF ORANGE COUNTY, CA)", 2019, "third_quarter", "MMM", "Monitor regulations and legislation changing Medicare and Medicaid policies", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 1, "2019-09-17T09:34:50.763000-04:00"], [2337004, "81fe476e-e9e9-4fb0-994f-138a669bbaaa", "Q3", "THE ROSS GROUP, LLC", 400432094, "THE HEALTHCARE LEADERSHIP COUNCIL", 2019, "third_quarter", "MMM", "provider payment", "HOUSE OF REPRESENTATIVES,SENATE", 33000, null, 0, 0, "2019-09-17T09:49:51.877000-04:00"], [2337005, "035647f0-f501-443a-99dd-3a3d4071e9c3", "Q3", "THE ROSS GROUP, LLC", 400432094, "ADVAULT, INC.", 2019, "third_quarter", "MMM", "Medicare Patient Empowerment Act\nAdvance Care Planning", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2019-09-17T09:50:53.907000-04:00"], [2337161, "8728bf25-9e8f-4622-872d-b8a4f095968c", "Q3", "HOSPICE COMPASSUS", 401103527, "HOSPICE COMPASSUS", 2019, "third_quarter", "MMM", "Medicare hospice, palliative and Medicare Advantage\nPCHETA\nRural Access to Hospice", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE", null, 60000, 0, 0, "2019-09-20T13:17:31.337000-04:00"], [2337174, "f61be9db-acd9-436c-94f1-627a32e5a974", "3A", "EASTERSEALS NEW JERSEY", 401105368, "EASTEREALS NEW JERSEY", 2019, "third_quarter", "MMM", "Advocating against step therapy for Medicare Part B", "HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2019-09-20T15:43:45.403000-04:00"], [2337250, "1e4f0f2a-b7dd-407e-acde-db775b0676c6", "Q3", "AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES", 2957, "AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES", 2019, "third_quarter", "MMM", "EVV, HCBS Settings Rule, HIPAA, ICF/IID Life Safety Code, MFP, 1115 waiver/block grant guidance", "Bureau of Labor Statistics (BLS),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),SENATE,Transportation, Dept of (DOT)", null, 20000, 0, 0, "2019-09-24T16:29:34.760000-04:00"], [2337448, "6e384baa-5916-43bb-94a0-4c6991d25a94", "Q3", "MOSAIC", 6096, "MOSAIC", 2019, "third_quarter", "MMM", "Advocacy on issues impacting people with disabilities including employment-related issues and Medicaid program changes.", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2019-09-30T12:16:29.913000-04:00"], [2337458, "0b655fca-fb05-454b-8d5a-fcdd74aa0d45", "Q3", "SOCIAL SECURITY WORKS", 401048957, "SOCIAL SECURITY WORKS", 2019, "third_quarter", "MMM", "Medicare Negotiation and Competitive Licensing Act\nMedicare for All Act\nStop the Wait Act\nMedigap Consumer Protection Act\nMedicare Dental, Vision and Hearing Benefit Act", "HOUSE OF REPRESENTATIVES,SENATE,Social Security Administration (SSA)", null, 12000, 0, 0, "2019-09-30T13:06:35.800000-04:00"], [2337647, "09b9811d-5b90-4775-a620-483d8803a701", "Q3", "SHUMAKER ADVISORS FLORIDA, LLC", 401104468, "GRACEPOINT WELLNESS", 2019, "third_quarter", "MMM", "In-patient Medicare coverage for mental health", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2019-10-01T13:14:36.853000-04:00"], [2337766, "ab867e9c-f2a2-41cd-8feb-83cf42913912", "Q3", "MCDERMOTT WILL & SCHULTE LLP", 24338, "ABIOMED, INC.", 2019, "third_quarter", "MMM", "Issues related to Medicare reimbursement and the medical device tax.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2019-10-01T15:16:24.517000-04:00"], [2337850, "36440a47-703d-46a9-9341-2db3755fbb82", "Q3", "MJWT CONSULTING", 69696, "WELLMED MEDICAL MANAGEMENT INC", 2019, "third_quarter", "MMM", "Medicare/Medicare Advantage legislative issues", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2019-10-02T07:31:29.427000-04:00"], [2337915, "9297e66e-eb69-45df-a2c1-d3c66673a028", "Q3", "AMERICAN COLLEGE OF CLINICAL PHARMACY", 57258, "AMERICAN COLLEGE OF CLINICAL PHARMACY", 2019, "third_quarter", "MMM", "Promote enhanced quality, structure and information dissemination concerning medication therapy management services (MTMS) under Medicare Part D.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE", null, 144981, 0, 0, "2019-10-02T10:28:01.477000-04:00"], [2338011, "b9afd040-e700-4155-be00-2dbe50cc619b", "Q3", "JOHNSTON GROUP, LLC", 400383768, "ASTRIA HEALTH (FORMERLY KNOWN AS SUNNYSIDE COMMUNITY HOSPITAL)", 2019, "third_quarter", "MMM", "Impact of sequestration on Medicare reimbursement rates.\nSupport for Critical Access Hospital reimbursement rates without changes.\nSupport for new CMS program that would allow a Critical Access Hospital to transition to a traditional CMS payment model over a ten year period.\nImpact of Section 603 of the Budget Act of 2015 on hospital reimbursement.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2019-10-02T13:53:58.437000-04:00"], [2338017, "886b5953-5acb-43a2-af72-7e18397038fb", "Q3", "JOHNSTON GROUP, LLC", 400383768, "ISLAND HOSPITAL", 2019, "third_quarter", "MMM", "Impact of sequestration on Medicare reimbursement rates.\nGraduate Medical Education (GME) program establishment.\nSupport for GME incentives to train primary care physicians\nImpact of GME and Direct Medical Education (DME) reimbursement cuts.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2019-10-02T13:55:00.420000-04:00"], [2338055, "2aa6edfc-b9b3-4653-9bfe-83d424317167", "Q3", "AMERICAN CAPITOL GROUP", 305852, "IPSEN BIOPHARMACEUTICALS, INC.", 2019, "third_quarter", "MMM", "Medicare Part D issues", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-10-02T15:38:24.240000-04:00"], [2338057, "8bfd9800-9c0f-4dce-8fa0-42a4e6532f68", "Q3", "AMERICAN CAPITOL GROUP", 305852, "HEARTFLOW", 2019, "third_quarter", "MMM", "Medicare Reimbursement Issues", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2019-10-02T15:39:24.927000-04:00"], [2338099, "8b473954-1098-4bd3-92b5-798c021b5747", "Q3", "CHRISTOPHER MOYER", 401093053, "CAMERON COMPANIES", 2019, "third_quarter", "MMM", "Monitored the introduction of drug pricing legislation for its potential impact on existing and emerging cancer drug therapies and site neutrality.  Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies, such as CAR-T.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2019-10-03T09:02:04.737000-04:00"], [2338101, "cfb8697f-6e73-4a24-88ef-a0307bb5c136", "Q3", "CAMERON COMPANIES", 401095057, "FOX CHASE CANCER CENTER", 2019, "third_quarter", "MMM", "Monitored the introduction of drug pricing legislation for its potential impact on existing and emerging cancer drug therapies and site neutrality.  Monitored Medicare reimbursement developments in the agencies and Congress for alternative cancer therapies such as CAR-T.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-10-03T09:06:06.240000-04:00"], [2338118, "b9a597dd-10f3-4a3b-84f9-07754377518b", "Q3", "MARSHALL BRACHMAN", 6848, "BAYLOR SCOTT AND WHITE HEALTH -- FORMERLY BAYLOR HEALTH CARE SYSTEM", 2019, "third_quarter", "MMM", "monitor post acute care and other site neutral medicare cuts; support legislation for relief of existing physician owned hospitals;monitor legislation affecting hospital not-for-profit status;monitor 340B program;monitor UNOS/HRSA liver transplant protocols", "HOUSE OF REPRESENTATIVES,SENATE", 33000, null, 0, 0, "2019-10-03T09:25:10.797000-04:00"], [2338136, "5c0ffeba-6dc7-4ed6-88e5-b9e96054c377", "Q3", "MARSHALL BRACHMAN", 6848, "OKLAHOMA HEART HOSPITAL", 2019, "third_quarter", "MMM", "support legislation to allow for growth of hospitals with physician ownership", "HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2019-10-03T09:37:16.843000-04:00"], [2338139, "228f010f-f834-48fe-8dab-2a86bcf2374b", "Q3", "MARSHALL BRACHMAN", 6848, "CARDIOLOGY ADVOCACY ALLIANCE", 2019, "third_quarter", "MMM", "oppose cuts to advanced medical imaging;support appropriateness criteria for diagnostic imaging;oppose site neutral cuts;monitor legislation affecting EHR and HIT", "HOUSE OF REPRESENTATIVES,SENATE", 33000, null, 0, 0, "2019-10-03T09:43:19.023000-04:00"], [2338156, "cf6271fe-e19f-4ad1-bf1d-2ec376aacdeb", "Q3", "WAKE FOREST UNIVERSITY HEALTH SCIENCES", 6781, "WAKE FOREST UNIVERSITY HEALTH SCIENCES", 2019, "third_quarter", "MMM", "Continuing Resolution (Medicare & Medicaid Extenders); Community Health Investment Modernization And Excellence Act of 2019,(H.R. 2328) provisions including Medicaid Disproportionate Share (DSH) payments, the reauthorization of the Patient-Centered Outcomes Research Institute (PCORI) and workforce programs; and \"Lower Healthcare Costs Act, (S. 1895) regarding surprise billing, drug pricing and price transparency; 340B Drug Pricing Program; Resident Physicians Shortage Reduction Act of 2019.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 150000, 0, 0, "2019-10-03T11:07:30.787000-04:00"], [2338161, "1a14890f-ee0a-431f-bc45-b8dd37ed133c", "Q3", "NORTH CAROLINA BAPTIST HOSPITAL", 46723, "NORTH CAROLINA BAPTIST HOSPITAL", 2019, "third_quarter", "MMM", "Continuing Resolution (Medicare & Medicaid Extenders); Community Health Investment Modernization And Excellence Act of 2019,(H.R. 2328) provisions including Medicaid Disproportionate Share (DSH) payments, the reauthorization of the Patient-Centered Outcomes Research Institute (PCORI) and workforce programs; and \"Lower Healthcare Costs Act, (S. 1895) regarding surprise billing, drug pricing and price transparency; 340B Drug Pricing Program; Resident Physicians Shortage Reduction Act of 2019.", "HOUSE OF REPRESENTATIVES,SENATE", null, 25000, 0, 0, "2019-10-03T11:13:32.527000-04:00"], [2338222, "351dd387-ee52-422f-9fca-3299fd904852", "Q3", "MERCURY PUBLIC AFFAIRS, LLC", 70175, "AMERISOURCE BERGEN", 2019, "third_quarter", "MMM", "General healthcare related to pharmaceuticals distribution", "Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 60000, null, 0, 0, "2019-10-03T13:19:57.063000-04:00"], [2338252, "47b81b19-d17e-4944-b49d-a212d43d79f7", "Q3", "MWR CONSULTING", 401104301, "UNITEDHEALTH GROUP", 2019, "third_quarter", "MMM", "Medicare Advantage", "HOUSE OF REPRESENTATIVES,SENATE", 45000, null, 0, 0, "2019-10-03T13:52:14.667000-04:00"], [2338253, "dc0cd8bf-cf46-413d-b0e3-119a0bd120ae", "Q3", "MERCURY PUBLIC AFFAIRS, LLC", 70175, "BLUE CROSS BLUE SHIELD OF SOUTH CAROLINA", 2019, "third_quarter", "MMM", "General Healthcare and Medicare (CMS) program contracts", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE", 40000, null, 0, 0, "2019-10-03T13:53:15.340000-04:00"], [2338259, "99a782f1-b6c4-4236-a857-ef41b5aa2ae0", "Q3", "MWR CONSULTING", 401104301, "HOLLISTER, INC.", 2019, "third_quarter", "MMM", "Reimbursement for medical devices under Medicare & Medicaid", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 25000, null, 0, 0, "2019-10-03T13:59:18.503000-04:00"], [2338267, "0b128acc-d6bb-4302-ab89-a737ef0e23de", "Q3", "MWR CONSULTING", 401104301, "PENN HILL GROUP ON BEHALF OF HOLLISTER, INC.", 2019, "third_quarter", "MMM", "Reimbursements for medical products under Medicare/Medicaid", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2019-10-03T14:07:22.780000-04:00"], [2338419, "33b08152-ff24-4b5c-9dae-69c263ff91d9", "Q3", "MILLER & WENHOLD CAPITOL STRATEGIES", 307034, "THE TRANSPORTATION ALLIANCE (FORMERLY TAXICAB, LIMOUSINE & PARATRANSIT ASSN.)", 2019, "third_quarter", "MMM", "Non-emergency Medical Transportation benefits - proposed cuts.", "Centers For Medicare and Medicaid Services (CMS),General Services Administration (GSA),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-10-04T09:28:15.793000-04:00"], [2338510, "75d67997-8711-4fc4-94ed-136cd690e281", "Q3", "POWER TO DECIDE", 400275303, "POWER TO DECIDE", 2019, "third_quarter", "MMM", "Medicaid coverage of family planning", "HOUSE OF REPRESENTATIVES,SENATE", null, 69194, 0, 0, "2019-10-04T11:32:28.053000-04:00"], [2338676, "382e271e-39ef-4166-b5f1-2567f74c9a8e", "Q3", "NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE", 27467, "NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE", 2019, "third_quarter", "MMM", "Drug Pricing. H.R. 3, the Lower Drug Costs Now Act:  Proposals to authorize the Secretary of Health and Human Services (HHS) to negotiate drug prices on behalf of Medicare with pharmaceutical manufactureres.  Create a maximum price for any negotiated drug with an international price index (Average International Market price).  Require drug manufacturers that refuse to negotiation with HHS to pay a Non-Compliance Fee of 65 percent of the gross sales of the drug in question.  Require drug companies that raised the price of a drug in Medicare above the rate of inflation since 2016 to either lower the price or pay the entire price above inflation in a rebate back to the Treasury.  Create a $2,000 Medicare beneficiary annual out-of-pocket cost cap for prescription drugs.\n\nDrug Pricing. S. 2543, the Prescription Drug Pricing Reduction Act of 2019:  Require pharmaceutical manufacturers to rebate Medicare if they raise their prices for drugs covered by Medicare Parts B and D faster than inflation. Establish an out-of-pocket spending limit in which Medicare beneficiaries would pay no more than $3,100 a year on drug costs. Require Medicare Part D private insurers to pay 60 percent and, drug makers 20 percent, of the costs incurred over the out-of-pocket spending cap. Increase transparency into pharmacy benefit manager practices and manufacturer drug pricing decisions. Provide state Medicaid programs with more authority to contain drug prices.\n\nDrug Pricing. H.R. 1046, the Medicare Negotiation and Competitive Licensing Act: Proposal to allow the Secretary of Health and Human Services to directly negotiate prices for prescription drugs and issue a competitive license allowing other manufacturers to produce the drug for Medicare in the event negotiations fail. \n\nDrug Pricing. S. 1895, the Lower Health Care Costs Act of 2019: Proposals to reduce the cost of prescription drugs including allowing generic drug manufacturers to sue brand-name manufacturers for not selling them samples for testing necessary to get to market; and requiring a drug manufacturer to submit a report to the Secretary of Health and Human Services for each price increase of certain drugs of which the wholesale acquisition cost increase is equal to 10 percent or more over a 12-month period or 25 percent or moreover a 36-month period.\n\nDementia and Alzheimers Disease.  S. 2076/H.R. 4256, Building Our Largest Dementia Infrastructure for Alzheimers Act (BOLD Act):  Proposal to apply a public health approach to combat Alzheimers disease and related dementias.\n\nMedicare Observation Status. H.R. 1682/S. 753, the Improving Access to Medicare Coverage Act of 2019:  Proposal to count days in the hospital in observation status toward meeting the three-day prior hospitalization requirement for skilled nursing facility care eligibility.\nGeneric Drug Introduction.  \n\nGeneric Drug Introduction.  H.R. 965, the CREATES Act: Proposal to speed the introduction of generic competition by curbing brand drug maker abuses of safety procedures as a means to limit generic manufacturer access to the drug samples needed to obtain Food and Drug Administration approval.\n\nHealth Care Rights Law.  Proposed rule to the provision of the Affordable Care Act addressing discrimination based on age, race, color, national origin, English proficiency, disability or sex.\n\nMedicaid Home and Community-Based Services:  H.R. 1839, the Medicaid Services Investment and Accountability Act of 2019:  Proposal extending the spousal impoverishment protections for home and community-based services until September 2019.\n\nMedicare Prescription Drug Costs. (No bill.)  Proposals to reduce amount drug manufacturers must contribute to closing the donut hole in 2019.\n\nMedicare Prescription Drug Costs.  (No bill.)  Provisions of the United States-Mexico-Canada Agreement (formerly the North American Free Trade Agreement) addressing countries having expansive regulatory approval monopolies for biologic drugs and restricting the ability of Congress to reform patent laws that drive up drug costs for Medicare. \n\nMedicare Coverage Expansion. H.R. 576, the Seniors Have Eyes, Ears, and Teeth Act of 2019; H.R. 1393, the Medicare Dental, Vision, and Hearing Benefit Act of 2019; H.R. 1518, the Medicare Hearing Aid Coverage Act of 2019: Proposals to expand Medicare coverage to include, vision, dental and hearing benefits.\n\nMedicare Open Enrollment.  (No bill.)  Proposals to ensure the Centers for Medicare and Medicaid Services conducts open enrollment in a way that is unbiased toward the traditional program. \n\nMedicare Part D. (No bill.)  Proposals to add an out-of-pocket cap, rationalize the structure of the Part D program, and make the Part D low-income subsidy more generous. \n\nMedigap Reform: H.R. 1394, the Medigap Consumer Protection Act: Proposal to improve quality of coverage and access to Medigap by restoring first dollar coverage and extending guaranteed issue to disabled people and other beneficiairies.\n\nDrug Safety. S. 1895, the Lower Health Care Costs Act of 2019: Proposal to remove requirement that medicines marketed in the U.S. adhere to quality standards established by the U.S. Pharmacopeia.  These standards allow biosimilar makers to achieve regulatory certainty and expedite biosimilars to market.\n\nMedicare Enrollment. H.R. 2477/S. 1280, the BENES Act of 2019: Proposal to improve beneficiary education tools and extend funding for state health insurance and assistance programs.\n\nReducing Health Care Costs: S. 1895, the Lower Health Care Costs Act of 2019: Proposal to eliminate surprise medical billing including out-of-network charges in emergencies.", "Administration on Aging,Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Economic Council (NEC),Office of Management & Budget (OMB),SENATE,Social Security Administration (SSA),Treasury, Dept of", null, 190000, 0, 0, "2019-10-04T13:44:22.567000-04:00"], [2338711, "db6f037e-4602-4412-b386-01bb50e8044b", "Q3", "LANTHEUS HOLDINGS, INC.", 401105198, "LANTHEUS HOLDINGS, INC.", 2019, "third_quarter", "MMM", "H.R. 3772 Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019", "Energy, Dept of,HOUSE OF REPRESENTATIVES,SENATE", null, 30000, 0, 0, "2019-10-04T14:16:33.327000-04:00"], [2338783, "4607fdea-9df5-4c1f-915b-1ec8fc975a6c", "Q3", "MR. MICHAEL ROMANSKY", 400418985, "OUTPATIENT OPHTHALMIC SURGERY SOCIETY, INC", 2019, "third_quarter", "MMM", "Lobbying for HR 1453 and S 2071, \"The ASC Quality and Access Act of 2015\", for reasonable payment and quality reporting rules for ambulatory surgical centers.", "Centers For Medicare and Medicaid Services (CMS),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE", 50000, null, 0, 0, "2019-10-04T17:08:15.683000-04:00"], [2338800, "9094fac4-06c3-44e5-ad0d-636c6c5f166b", "Q3", "MISSION GOVERNMENT RELATIONS (FORMERLY KNOWN AS MUROFF LAW FIRM, LLC)", 314033, "JEVS HUMAN SERVICES", 2019, "third_quarter", "MMM", "Medicaid and associated healthcare funding\nworkforce development and training", "HOUSE OF REPRESENTATIVES,SENATE", 10500, null, 0, 0, "2019-10-05T10:22:38.607000-04:00"], [2338884, "471b28a9-b610-4315-a773-331d61786141", "3A", "NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE", 27467, "NATIONAL COMMITTEE TO PRESERVE SOCIAL SECURITY AND MEDICARE", 2019, "third_quarter", "MMM", "Drug Pricing. H.R. 3, the Lower Drug Costs Now Act:  Proposals to authorize the Secretary of Health and Human Services (HHS) to negotiate drug prices on behalf of Medicare with pharmaceutical manufactureres.  Create a maximum price for any negotiated drug with an international price index (Average International Market price).  Require drug manufacturers that refuse to negotiation with HHS to pay a Non-Compliance Fee of 65 percent of the gross sales of the drug in question.  Require drug companies that raised the price of a drug in Medicare above the rate of inflation since 2016 to either lower the price or pay the entire price above inflation in a rebate back to the Treasury.  Create a $2,000 Medicare beneficiary annual out-of-pocket cost cap for prescription drugs.\n\nDrug Pricing. S. 2543, the Prescription Drug Pricing Reduction Act of 2019:  Require pharmaceutical manufacturers to rebate Medicare if they raise their prices for drugs covered by Medicare Parts B and D faster than inflation. Establish an out-of-pocket spending limit in which Medicare beneficiaries would pay no more than $3,100 a year on drug costs. Require Medicare Part D private insurers to pay 60 percent and, drug makers 20 percent, of the costs incurred over the out-of-pocket spending cap. Increase transparency into pharmacy benefit manager practices and manufacturer drug pricing decisions. Provide state Medicaid programs with more authority to contain drug prices.\n\nDrug Pricing. H.R. 1046, the Medicare Negotiation and Competitive Licensing Act: Proposal to allow the Secretary of Health and Human Services to directly negotiate prices for prescription drugs and issue a competitive license allowing other manufacturers to produce the drug for Medicare in the event negotiations fail. \n\nDrug Pricing. S. 1895, the Lower Health Care Costs Act of 2019: Proposals to reduce the cost of prescription drugs including allowing generic drug manufacturers to sue brand-name manufacturers for not selling them samples for testing necessary to get to market; and requiring a drug manufacturer to submit a report to the Secretary of Health and Human Services for each price increase of certain drugs of which the wholesale acquisition cost increase is equal to 10 percent or more over a 12-month period or 25 percent or moreover a 36-month period.\n\nDementia and Alzheimers Disease.  S. 2076/H.R. 4256, Building Our Largest Dementia Infrastructure for Alzheimers Act (BOLD Act):  Proposal to apply a public health approach to combat Alzheimers disease and related dementias.\n\nMedicare Observation Status. H.R. 1682/S. 753, the Improving Access to Medicare Coverage Act of 2019:  Proposal to count days in the hospital in observation status toward meeting the three-day prior hospitalization requirement for skilled nursing facility care eligibility.\nGeneric Drug Introduction.  \n\nGeneric Drug Introduction.  H.R. 965, the CREATES Act: Proposal to speed the introduction of generic competition by curbing brand drug maker abuses of safety procedures as a means to limit generic manufacturer access to the drug samples needed to obtain Food and Drug Administration approval.\n\nHealth Care Rights Law.  Proposed rule to the provision of the Affordable Care Act addressing discrimination based on age, race, color, national origin, English proficiency, disability or sex.\n\nMedicaid Home and Community-Based Services:  H.R. 1839, the Medicaid Services Investment and Accountability Act of 2019:  Proposal extending the spousal impoverishment protections for home and community-based services until September 2019.\n\nMedicare Prescription Drug Costs. (No bill.)  Proposals to reduce amount drug manufacturers must contribute to closing the donut hole in 2019.\n\nMedicare Prescription Drug Costs.  (No bill.)  Provisions of the United States-Mexico-Canada Agreement (formerly the North American Free Trade Agreement) addressing countries having expansive regulatory approval monopolies for biologic drugs and restricting the ability of Congress to reform patent laws that drive up drug costs for Medicare. \n\nMedicare Coverage Expansion. H.R. 576, the Seniors Have Eyes, Ears, and Teeth Act of 2019; H.R. 1393, the Medicare Dental, Vision, and Hearing Benefit Act of 2019; H.R. 1518, the Medicare Hearing Aid Coverage Act of 2019: Proposals to expand Medicare coverage to include, vision, dental and hearing benefits.\n\nMedicare Open Enrollment.  (No bill.)  Proposals to ensure the Centers for Medicare and Medicaid Services conducts open enrollment in a way that is unbiased toward the traditional program. \n\nMedicare Part D. (No bill.)  Proposals to add an out-of-pocket cap, rationalize the structure of the Part D program, and make the Part D low-income subsidy more generous. \n\nMedigap Reform: H.R. 1394, the Medigap Consumer Protection Act: Proposal to improve quality of coverage and access to Medigap by restoring first dollar coverage and extending guaranteed issue to disabled people and other beneficiairies.\n\nDrug Safety. S. 1895, the Lower Health Care Costs Act of 2019: Proposal to remove requirement that medicines marketed in the U.S. adhere to quality standards established by the U.S. Pharmacopeia.  These standards allow biosimilar makers to achieve regulatory certainty and expedite biosimilars to market.\n\nMedicare Enrollment. H.R. 2477/S. 1280, the BENES Act of 2019: Proposal to improve beneficiary education tools and extend funding for state health insurance and assistance programs.\n\nReducing Health Care Costs: S. 1895, the Lower Health Care Costs Act of 2019: Proposal to eliminate surprise medical billing including out-of-network charges in emergencies.", "Administration on Aging,Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Economic Council (NEC),Office of Management & Budget (OMB),SENATE,Social Security Administration (SSA),Treasury, Dept of", null, 190000, 0, 0, "2019-10-07T10:29:25.720000-04:00"], [2338963, "01c879a2-c603-4c09-b730-57a9ed0e4b57", "Q3", "CAPITOL ADVOCACY & GOVERNMENT AFFAIRS, LLC", 401104914, "AMERICAN COLLEGE OF CLINICAL PHARMACY", 2019, "third_quarter", "MMM", "coverage and recognition for comprehensive medication management", "Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-10-07T12:45:27.543000-04:00"], [2338972, "2503b141-2eb8-4704-8b92-4f71af20688e", "Q3", "GENESIS HEALTHCARE INC (FORMERLY LISTED AS GENESIS HEALTHCARE CORPORATION)", 40049384, "GENESIS HEALTHCARE INC (FORMERLY LISTED AS GENESIS HEALTHCARE CORPORATION)", 2019, "third_quarter", "MMM", "16. Specific lobbying issues\n(i) CMS FY20 SNF PPS final rules and notice of proposed changes in SNF case-mix and payment methodology for FY20;(ii) CMS implementation of quality measures/IMPACT Act provisions; and (iii) CMS proposed revisions in requirements of Long Term Care Facilities Requirements listed in Unified Agenda of Regulatory and Deregulatory Actions.", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)", null, 20000, 0, 0, "2019-10-07T13:19:32.103000-04:00"], [2339057, "2c970a67-e0e2-4409-9fa5-76302ca16192", "Q3", "MCDERMOTT+ LLC", 401103287, "340B HEALTH", 2019, "third_quarter", "MMM", "Issues relating to the 340B drug pricing program.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-10-07T14:59:23.293000-04:00"], [2339110, "81d2b102-aa14-4f52-9e0d-de2dfa8e875d", "Q3", "AMERICAN ASSOCIATION OF CHILD & ADOLESCENT PSYCHIATRY", 401103274, "AMERICAN ASSOCIATION OF CHILD & ADOLESCENT PSYCHIATRY", 2019, "third_quarter", "MMM", "Medicaid reform and expansion support \nH.R.1920 Medicaid Bump Act\nFunding for Children's Hospital Graduate Medical Education (CHGME)", "Executive Office of the President (EOP),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),White House Office", null, 40000, 0, 0, "2019-10-07T16:54:22.517000-04:00"], [2339127, "bb6bccb6-da8c-4498-896c-58fa172a212f", "Q3", "CAPITOL IMPACT, LLC", 284471, "THE LIVINGSTON GROUP, LLC (RUSH UNIVERSITY MEDICAL CENTER)", 2019, "third_quarter", "MMM", "H.R. 1533/S. 782 - Improving Access to Mental Health Act", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2019-10-07T20:31:06.843000-04:00"], [2339164, "a3e9b959-a4bc-4e4c-a891-8faa1524a783", "Q3", "RETIRESAFE", 11025, "RETIRESAFE", 2019, "third_quarter", "MMM", "Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility.  discussed our stance against drug importation.", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 38750, 0, 0, "2019-10-08T09:08:29.523000-04:00"], [2339172, "92c4dffd-46a0-4404-ad4f-8f6211460e1b", "Q3", "MCDERMOTT+ LLC", 401103287, "AMERICA'S ESSENTIAL HOSPITALS", 2019, "third_quarter", "MMM", "General issues relating to Medicare, Medicaid, disproportionate share hospital payment, and 340B.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-10-08T09:37:43.120000-04:00"], [2339176, "380d9bd0-6f9c-4321-9b4c-f6a0004ad9df", "Q3", "MCDERMOTT+ LLC", 401103287, "ASSOCIATION FOR COMMUNITY AFFILIATED PLANS", 2019, "third_quarter", "MMM", "Issues relating to Medicaid, Medicare, and the Marketplace, short-term limited duration insurance plans, and association health plans.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-10-08T09:57:36.287000-04:00"], [2339179, "92d5305f-ec5b-48ea-8636-785bed3969c9", "Q3", "ELEKTA, INC.", 401103218, "ELEKTA, INC.", 2019, "third_quarter", "MMM", "Issues related to oncology treatment products and services", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", null, 130000, 0, 0, "2019-10-08T09:57:37.067000-04:00"], [2339192, "4c8a81e4-89fa-4815-a9e9-98d42b5eb569", "Q3", "DEXCOM, INC.", 401104564, "DEXCOM, INC.", 2019, "third_quarter", "MMM", "CMS Coverage Policies and Reimbursement", "Centers For Medicare and Medicaid Services (CMS)", null, 56274, 0, 0, "2019-10-08T10:17:12.390000-04:00"], [2339223, "dd4b7c8a-fc3b-43f1-a6dd-0ee16c5ea32e", "Q3", "REPUBLIC CONSULTING, LLC", 401016871, "PERSONAL CONNECTED HEALTH ALLIANCE", 2019, "third_quarter", "MMM", "Monitor Connected Health Policy.", "Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-10-08T10:50:05.853000-04:00"], [2339228, "53666e5d-5adb-44d5-8f29-d46832b7f257", "Q3", "REPUBLIC CONSULTING, LLC", 401016871, "WW INTERNATIONAL (FORMERLY KNOWN AS WEIGHT WATCHERS)", 2019, "third_quarter", "MMM", "Monitor wellness and obesity treatment policy.", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-10-08T10:53:08.547000-04:00"], [2339234, "63e3bd82-3616-4a42-be7b-85955b787308", "Q3", "POLSINELLI PC", 314911, "HEARING INDUSTRIES ASSOCIATION", 2019, "third_quarter", "MMM", "Issues pertaining to the coverage of hearing aid devices.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-10-08T11:04:56.020000-04:00"], [2339254, "0bf10731-ecfe-41cf-94fd-cb2dae039f20", "Q3", "POLSINELLI PC", 314911, "TRIDENTUSA HEALTH SERVICES", 2019, "third_quarter", "MMM", "Issues related to bundled payments for clinical laboratory services provided to nursing homes and home bound patients.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2019-10-08T11:20:49.420000-04:00"], [2339273, "e9e318e8-6b90-4bb4-9109-86e75816758f", "3T", "MCDERMOTT+ LLC", 401103287, "CHRISTIAN FAMILY MEDICINE", 2019, "third_quarter", "MMM", "Issues relating to a Medicaid State Plan Amendment.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 1, "2019-10-08T11:33:57.567000-04:00"], [2339282, "474ce21f-e223-4326-a3fc-af62c4ffd58a", "Q3", "MCDERMOTT+ LLC", 401103287, "CVS HEALTH", 2019, "third_quarter", "MMM", "General issues relating to PBMs. Issues relating to prescription drug pricing, including H.R. 3 Lower Drug Costs Now Act of 2019, S. 1895 Lower Health Care Costs Act, and S. 2543 The Prescription Drug Pricing Reduction Act of 2019.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2019-10-08T11:58:17.517000-04:00"], [2339326, "e4f03ba2-6a4c-487f-9c06-11eac55b2967", "Q3", "NATIONAL ASSOCIATION OF POSTAL SUPERVISORS", 401075023, "NATIONAL ASSOCIATION OF POSTAL SUPERVISORS", 2019, "third_quarter", "MMM", "Legislation that could impact the coordination  between FEHBP and Medicare", "HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),Postal Regulatory Commission,SENATE,Treasury, Dept of,U.S. Postal Service (USPS)", null, 15000, 0, 0, "2019-10-08T12:58:08.377000-04:00"], [2339350, "7bf20517-40c5-4eb9-a7a6-34dfb84a17c1", "Q3", "MEDICAL DEVICE MANUFACTURERS ASSOCIATION", 24794, "MEDICAL DEVICE MANUFACTURERS ASSOCIATION", 2019, "third_quarter", "MMM", "Issues relating to Reimbursement of Medical Devices", "Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE", null, 300000, 0, 0, "2019-10-08T13:36:09.673000-04:00"], [2339352, "096e58a0-eabb-4772-bbf3-fc6f822c65ad", "Q3", "MICHAEL N. MCCARTY LAW OFFICE PLLC", 401104300, "AMERICAN MEDICAL TECHNOLOGISTS", 2019, "third_quarter", "MMM", "Support proposed amendments to Section 216 of the Protecting Access to Medicare Act of 2014, including H.R. 3584 (Laboratory Access for Beneficiaries Act); legislation affecting payments under the Medicare Clinical Laboratory Fee Schedule.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2019-10-08T13:40:11.257000-04:00"], [2339418, "e6fbc4db-73d6-4d1e-90c5-59d79188652b", "Q3", "BAYADA HEARTS FOR HOMECARE", 401105103, "BAYADA HEARTS FOR HOMECARE", 2019, "third_quarter", "MMM", "H.R. 2573/S.433 Home Health Payment Innovation Act of 2019;", "HOUSE OF REPRESENTATIVES,SENATE", null, 11000, 0, 0, "2019-10-08T14:57:21.510000-04:00"], [2339429, "c99d5635-6491-4c14-abb4-b88402f18c80", "3T", "FAEGRE DRINKER BIDDLE & REATH LLP", 12631, "INTEGRA LIFESCIENCES", 2019, "third_quarter", "MMM", "Medicare reimbursement on wound care.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 1, "2019-10-08T15:27:35.753000-04:00"], [2339495, "4074cd4a-ea1a-4b59-b3c4-fa8fb6ce9fed", "Q3", "AMERICAN AMBULANCE ASSOCIATION", 56018, "AMERICAN AMBULANCE ASSOCIATION", 2019, "third_quarter", "MMM", "Lobbied on increases to rates under the Medicare ambulance fee schedule and improvements on Medicare and Medicaid policies on ambulance services including CMMI pilot programs and a cost data collection system.  Lobbied on the draft Medicare Ambulance Access, Fraud Prevention and Reform Act and the Non-Emergency Ambulance Transportation Sustainability and Accountability (NEATSA) Act of 2019 (S. 228, H.R. 3201).", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)", null, 180000, 0, 0, "2019-10-09T08:29:26.800000-04:00"], [2339557, "06a24f78-8fcb-41e7-90bc-ff48657501ff", "Q3", "COLLEGE OF HEALTHCARE INFORMATION MANAGEMENT EXECUTIVES", 401103450, "COLLEGE OF HEALTHCARE INFORMATION MANAGEMENT EXECUTIVES", 2019, "third_quarter", "MMM", "Medicare and Medicaid EHR Incentive Program, Medicare Access and CHIP Reauthorization Act, Telehealth and Remote Patient Monitoring, patient matching/identification, Cybersecurity, HIPAA Privacy, Conditions of Participation, Interoperability, Lower Health Care Costs (S.1895,) Repeal National Patient ID Act (S. 2538)", "Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Federal Bureau of Investigation (FBI),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institute of Standards & Technology (NIST),SENATE,Substance Abuse & Mental Health Services Administration (SAMHSA),White House Office", null, 25000, 0, 0, "2019-10-09T09:48:50.477000-04:00"], [2339564, "fc2d7aab-3d3c-447e-8450-ac37a55bfdc2", "Q3", "MCDERMOTT+ LLC", 401103287, "LYMPHEDEMA ADVOCACY GROUP", 2019, "third_quarter", "MMM", "Issues relating to Medicare's coverage of lymphedema treatment and the Lymphedema Treatment Act (S. 518/H.R. 1948).", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2019-10-09T10:31:09.907000-04:00"], [2339586, "ec2221c8-b07c-4067-b538-a42c2812b3c0", "Q3", "MCDERMOTT+ LLC", 401103287, "NATIONAL ASSOCIATION OF COUNTIES", 2019, "third_quarter", "MMM", "General issues relating to Medicare and Medicaid.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2019-10-09T11:03:01.807000-04:00"], [2339598, "11d7a67b-0cd9-4a97-9959-ca7a8e1de465", "Q3", "THE CJR GROUP, INC.", 288293, "BELLEFAIRE JCB", 2019, "third_quarter", "MMM", "FQHC", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2019-10-09T11:32:51.500000-04:00"], [2339599, "9dce48aa-51b9-443e-8cd9-638d09d46fd6", "Q3", "DOCTORS HOSPITAL AT RENAISSANCE", 400479360, "DOCTORS HOSPITAL AT RENAISSANCE", 2019, "third_quarter", "MMM", "Medicare and Medicaid policy, DSH funding, physician owned hospital restrictions, Stark law, Medicaid and Medicaid regulations, health care issues,", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)", null, 80000, 0, 0, "2019-10-09T11:32:52.530000-04:00"], [2339614, "b65012d4-2dfe-42f8-a17a-fd23e02cad7f", "Q3", "THE CJR GROUP, INC.", 288293, "UNIVERSITY HOSPITALS HEALTH SYSTEM", 2019, "third_quarter", "MMM", "CMS rules", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2019-10-09T11:35:00.047000-04:00"], [2339628, "4cdbe567-0a59-4661-8cd1-e8b23c2a1484", "Q3", "INTEREL US", 401104823, "AMERICAN AMBULANCE ASSOCIATION", 2019, "third_quarter", "MMM", "Lobbied on increases to rates under the Medicare ambulance fee schedule and improvements on Medicare and Medicaid policies on ambulance services including CMMI pilot programs and a cost data collection system. Lobbied on the draft Medicare Ambulance Access, Fraud Prevention and Reform Act and the Non-Emergency Ambulance Transportation Sustainability and Accountability (NEATSA) Act of 2019 (S. 228, H.R. 3021).", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)", 70000, null, 0, 0, "2019-10-09T11:40:10.307000-04:00"], [2339641, "6ea7de68-8965-4213-b128-e53e4ccf37d1", "Q3", "ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)", 1466, "ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)", 2019, "third_quarter", "MMM", "On July 10, 2019 AACC wrote to Rep. Scott Peters endorsing H.R.3584, the Laboratory Access for Beneficiaries Act, which seeks to ensure that the payment amounts on the new market-based clinical laboratory fee schedule, authorized under the Protecting Access to Medicare Act (PAMA), are accurate.\n\nOn August 20, 2019 ACC wrote to Rep. Judy Chu endorsing H.R.3031, which would\nreauthorize the National Quality Forum (NQF) through 2024 at $30 million annually.", "HOUSE OF REPRESENTATIVES,SENATE", null, 50000, 0, 0, "2019-10-09T12:01:02.487000-04:00"], [2339653, "ff5d0860-f2d7-4cae-8c60-f6216b5856b1", "3A", "AMERICAN AMBULANCE ASSOCIATION", 56018, "AMERICAN AMBULANCE ASSOCIATION", 2019, "third_quarter", "MMM", "Lobbied on increases to rates under the Medicare ambulance fee schedule and improvements on Medicare and Medicaid policies on ambulance services including CMMI pilot programs and a cost data collection system.  Lobbied on the draft Medicare Ambulance Access, Fraud Prevention and Reform Act and the Non-Emergency Ambulance Transportation Sustainability and Accountability (NEATSA) Act of 2019 (S. 228, H.R. 3201).", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,Veterans Affairs, Dept of (VA)", null, 180000, 0, 0, "2019-10-09T12:02:25.613000-04:00"], [2339819, "8572f97c-2720-420d-bff6-14f8145f0c56", "Q3", "ACG ADVOCACY", 2057, "CAPITAL DISTRICT PHYSICIAN'S HEALTH PLAN INC", 2019, "third_quarter", "MMM", "Medicare Advantage Issues.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2019-10-09T15:05:58.190000-04:00"], [2339890, "66d48239-5be8-4b2c-baee-980ff07ef18f", "Q3", "COREWELL HEALTH", 298455, "COREWELL HEALTH", 2019, "third_quarter", "MMM", "H.R.1839 - Medicaid Services Investment and Accountability Act of 2019. ACE Kids Act discussions.\nS. 773 - Telehealth Innovation and Improvement Act of 2019. Discussions regarding proposal.\nPresidents Executive Order on health care transparency. Discussions related to proposals to increase heath care transparency.\nDiscussions around proposed changes to the Medicare Advantage benchmark cap.\nH.R. 3107 - Improving Seniors' Time Access to Care Act of 2019. Discussions around Prior Authorization legislation.\nDiscussions around \"site-neutral\" cuts and Medicaid Disproportionate Share Hospital Program cuts.", "HOUSE OF REPRESENTATIVES,SENATE", null, 60000, 0, 0, "2019-10-09T16:03:11.807000-04:00"], [2339896, "632cfe3f-85c7-435a-add5-5a2312db6b0a", "3T", "FAEGRE DRINKER BIDDLE & REATH LLP", 12631, "NATIONAL ASSOCIATION OF SPECIALTY PHARMACY", 2019, "third_quarter", "MMM", "Medicare Direct and Indirect Remuneration. H.R. 1034, S. 640 Phair Pricing Act of 2019.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 1, "2019-10-09T16:19:37.720000-04:00"], [2340005, "b75c7a80-94b9-4382-b662-1049dae05fe8", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "AMERICAN ASSN FOR THE STUDY OF LIVER DISEASES", 2019, "third_quarter", "MMM", "Medicare reimbursement rates\nMACRA Implementation Chronic Care Reform", "Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 50000, null, 0, 0, "2019-10-10T16:04:42.020000-04:00"], [2340020, "9cb35452-a4ca-4466-9e2b-bfeba395d41b", "Q3", "CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.", 8511, "SOCIETY OF GENERAL INTERNAL MEDICINE", 2019, "third_quarter", "MMM", "P.L. 111-148/P.L. 111-152, Affordable Care Act, physician reimbursement issues\nP.L. 114-10, Medicare Access and CHIP reauthorization Act implementation\nChronic Care", "Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", 30000, null, 0, 0, "2019-10-10T16:04:50.427000-04:00"], [2340033, "ca91ed66-668f-44cf-a9de-689aabd534f2", "Q3", "AMERICAN CHIROPRACTIC ASSOCIATION", 1898, "AMERICAN CHIROPRACTIC ASSOCIATION", 2019, "third_quarter", "MMM", "HR 1384: Medicare for All Act; ensure chiropractic access\nHR 1346: Medicare at 50 Act; ensure chiropractic access\nS. 470: Medicare at 50 Act; ensure chiropractic access\nHR 3654:Chiropractic Medicare Coverage Modernization Act; providing access to all Medicare-covered services allowed under a chiropractor's licensure", "HOUSE OF REPRESENTATIVES,SENATE", null, 71750, 0, 0, "2019-10-10T16:04:56.520000-04:00"], [2340127, "2638d3ef-3d48-4e28-b4c7-12feb348d75d", "Q3", "HORIZON GOVERNMENT AFFAIRS", 315592, "NATIONAL KIDNEY FOUNDATION", 2019, "third_quarter", "MMM", "Working to extend Medicare drug coverage of immunosuppressant coverage for kidney transplant recipients.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2019-10-10T16:05:42.287000-04:00"], [2340182, "8f0b2879-0c7c-4cc8-8004-44a76f80020d", "Q3", "CORPORATION FOR SUPPORTIVE HOUSING", 69195, "CORPORATION FOR SUPPORTIVE HOUSING", 2019, "third_quarter", "MMM", "Medicaid Waivers 1115 and 1915i", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE,Treasury, Dept of", null, 50000, 0, 0, "2019-10-10T16:06:20.490000-04:00"], [2340187, "48b3c17c-ffc7-47d6-a37f-92e66f7ffacc", "Q3", "CAPITOL HILL STRATEGIES,  LLC", 91774, "BIOTECHNOLOGY INDUSTRY ORGANIZATION", 2019, "third_quarter", "MMM", "Issues relating to prescription drug pricing, oversight, patents, and intellectual property in Medicare and generally, including proposed reform proposals.  \nIssues relating to biologics and biosimilars in Medicare and generally.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2019-10-10T16:06:21.397000-04:00"], [2340256, "562515bf-c1bd-4019-9c1e-1896a9228505", "Q3", "WEST FRONT STRATEGIES LLC", 401103493, "AMERICAN PSYCHOLOGICAL ASSOCIATION SERVICES, INC. (FKA APA PRACTICE ORG.)", 2019, "third_quarter", "MMM", "Legislation to amend the definition of physician in Medicare to provide for treatment of clinical psychologist as physicians, for purposes of providing clinical psychologist services under Medicare, including H.R. 884.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2019-10-10T16:36:58.687000-04:00"], [2340436, "056316e6-674e-4f5c-a201-cdcae5d2e689", "Q3", "HEALTHCARE LEADERSHIP COUNCIL", 17933, "HEALTHCARE LEADERSHIP COUNCIL", 2019, "third_quarter", "MMM", "H.R. 1530 Treat and Reduce Obesity Act\nS. 595 Treat and Reduce Obesity Act\nH.R. 1763 Resident Physician Shortage Reduction Act \nS. 348 Resident Physician Shortage Reduction Act\nH.R. 2062 Overdose Prevention and Patient Safety Act\nH.R. 2207 Protect Medical Innovation Act\nS. 692 Protect Medical Innovation Act\nH.R. 2740 - Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020 \nH.R. 3461 - Community-Based Independence for Seniors Act of 2019\nH.R. 3796 - Health Savings for Seniors Act\nH.R. 4013 Telehealth Innovation and Improvement Act\nS. 773 - Telehealth Innovation and Improvement Act\nS. 1012 Protecting Jessica Grubbs Legacy Act\nS. 1323 - Utilizing National Data, Effectively Reforming Standards and Tools, to Address Negative Determinates of Health (UNDERSTAND) Act\nS. 1842 - Protecting Personal Health Data Act \nS. 1895 Lower Health Care Costs Act", "Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", null, 180000, 0, 0, "2019-10-11T09:48:55.763000-04:00"], [2340484, "a7702aca-5326-4be8-8526-bd322c5f76b6", "Q3", "OSF HEALTHCARE SYSTEM", 56394, "OSF HEALTHCARE SYSTEM", 2019, "third_quarter", "MMM", "Advocated for maintaining existing or increase in funding levels as it relates to medicaid and medicare.", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE", null, 60000, 0, 0, "2019-10-11T10:45:20.837000-04:00"], [2340588, "f8c0b323-b2fb-4348-90b5-cd549d040bae", "Q3", "THE CACTUS GROUP, LLC", 401105143, "MERCK & CO.", 2019, "third_quarter", "MMM", "HR 5712 - Medicaid Drug Rebate Accountability Act - bill in its entirety (oppose)", "HOUSE OF REPRESENTATIVES,SENATE", 15000, null, 0, 0, "2019-10-11T11:53:32.483000-04:00"], [2340591, "e1412ba6-1f6f-4c0d-b701-c0d76d7b823f", "Q3", "BEN BARNES GROUP LP", 5415, "HUNTSMAN CANCER INSTITUTE", 2019, "third_quarter", "MMM", "Medicare Prospective Payment System Exemption", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2019-10-11T11:54:34.360000-04:00"], [2340674, "b39e6d60-b32e-4bc0-a20e-7fa6a75f2c1e", "Q3", "SENTRY INSURANCE COMPANY (FORMERLY SENTRY INSURANCE A MUTUAL COMPANY)", 401104022, "SENTRY INSURANCE COMPANY (FORMERLY SENTRY INSURANCE A MUTUAL COMPANY)", 2019, "third_quarter", "MMM", "HR 1575 PAID Act, all provisions - We support this bill", "HOUSE OF REPRESENTATIVES,SENATE", null, 60000, 0, 0, "2019-10-11T13:55:18.903000-04:00"], [2340683, "5ee01b3b-b901-4d00-ad1d-fea84515cd23", "Q3", "SQUIRE PATTON BOGGS", 30906, "COLORADO COALITION FOR DEVELOPMENTAL DISABILITIES", 2019, "third_quarter", "MMM", "As leader of a coalition of Colorado Community Centered boards, Developmental Pathways is seeking to extend the compliance timeline and clarify provisions of CMS HCBS rules on conflict-free case management.", "HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-10-11T14:02:24.240000-04:00"], [2340729, "76a93f52-083a-4179-b67b-2b1800632c31", "Q3", "NATIONAL KIDNEY FOUNDATION", 28105, "NATIONAL KIDNEY FOUNDATION", 2019, "third_quarter", "MMM", "Early detection and management of Chronic Kidney Disease, including Alternative Payment Model\n\nIncreased utilization of home dialysis\n\nExtension of Medicare coverage of immunosuppressive drugs for kidney transplant recipients\n\nIncreased use of Kidney Discards for transplantation\n\nAccess of medications under Medicare Part D Protected Classes \n\nComments on proposed rule on ESRD Treatment Choices Model\n\nComments on ESRD Prospective Payment System and Quality Incentive Program\n\nComments on interpretive guidance Conditions of Participation for organ transplant programs\n\nComments on proposed revisions for organ procurement organization Conditions of Coverage outcomes measures", "Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE", null, 100000, 0, 0, "2019-10-11T14:22:49.063000-04:00"], [2340743, "54c6cef0-6f8b-4a7e-844a-c837c482fe14", "Q3", "MCDERMOTT+ LLC", 401103287, "CAMPAIGN FOR SUSTAINABLE DRUG PRICING", 2019, "third_quarter", "MMM", "Issues relating to prescription drug pricing\nHHS Rebate Rule\nMedicare Part D benefit re-design\nH.R. 2113 - Prescription Drug STAR Act\nS. 551 - Recovering Excessive Funds for Unused and Needless Drugs (REFUND) Act\nH.R. 3 - Lower Drug Costs Now Act of 2019\nS. 2543 - Prescription Drug Pricing Reduction Act of 2019", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-10-11T14:31:55.327000-04:00"], [2340788, "d8e95bee-2184-4f6b-bb45-9a320da70cfe", "Q3", "IPOLICY SOLUTIONS", 401105127, "ASSOCIATION FOR MOLECULAR PATHOLOGY", 2019, "third_quarter", "MMM", "Medicare coverage of next generation sequencing based tests for cancer\nHR4393, Advancing Access to Precision Medicine Act", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2019-10-11T15:05:28.917000-04:00"], [2340795, "731c97b8-97d4-410d-be26-af20a7fd9401", "Q3", "IPOLICY SOLUTIONS", 401105127, "INVITAE INC.", 2019, "third_quarter", "MMM", "Medicare coverage of next generation sequencing based tests for cancer\nH.R.4393 - Advancing Access to Precision Medicine Act", "HOUSE OF REPRESENTATIVES,SENATE", 58000, null, 0, 0, "2019-10-11T15:12:33.817000-04:00"], [2340897, "624b8b69-db03-49e4-af38-85665801ec19", "Q3", "CALIFORNIA CHILDREN'S HOSPITAL ASSOCIATION", 401104267, "CALIFORNIA CHILDREN'S HOSPITAL ASSOCIATION", 2019, "third_quarter", "MMM", "Supporting funding in FY 2020 budget for Children's Hospital Graduate Medical Education program.\n\nSupporting effort to delay/eliminate cuts to Disproportionate Share Hospitals.\n\nCommented on proposed changes to the Medicare Hospital Outpatient Prospective Payment rule and the Medicare Physician Fee Schedule rule.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", null, 15000, 0, 0, "2019-10-11T19:23:27.973000-04:00"], [2340905, "01270791-013e-405c-8bc0-4454a92001dd", "Q3", "BLUE MOUNTAIN STRATEGIES", 401104249, "SIXTEENTHIRTY FUND", 2019, "third_quarter", "MMM", "Issues involving attempts to amend title XVIII of the Social Security Act to provide for the negotiation of lower covered part D drug prices on behalf of Medicare beneficiaries and the establishment and application of a formulary by the Secretary of Health and Human Services under Medicare part D, and for other purposes. HR 448 - Medicare Drug Price Negotiation Act. HR 383,  Continuing Coverage for Preexisting Conditions Act of 2019; S. 1556, No Junk Plans Act; S. 466, Protecting Americans with Pre-existing Conditions Act of 2019; S. 1905, ENROLL Act of 2019.", "SENATE", 40000, null, 0, 0, "2019-10-12T10:38:52.560000-04:00"], [2340932, "ea8b8966-d6eb-4f59-831a-84b53fdf86fc", "Q3", "RED+BLUE STRATEGIES", 400693064, "CHILDREN'S HOSPITAL ASSOCIATION F/K/A NAT'L ASSOCIATION OF CHILDREN'S HOSPITALS", 2019, "third_quarter", "MMM", "Executive actions impacting children's health care including potential regulations designed to restructure the Medicaid program. \n\nImplementation issues regarding the ACE Kids Act. \n\n\nH.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 - Support of the the title including policies focused on improving supports for children with multiple chronic conditions and other critical provisions.\n\nIssues related to helping military families access the health care coverage and treatment for which they are eligible. \n\nIssues related to the treatment of the treatment of Disproportionate Care Hospitals under the Medicaid program.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 70000, null, 0, 0, "2019-10-13T08:49:20.590000-04:00"], [2340935, "342d36e3-73ba-4521-b954-8b883435e4d5", "Q3", "RED+BLUE STRATEGIES", 400693064, "PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)", 2019, "third_quarter", "MMM", "H.R. 3 - The Lower Drug Costs Now Act of 2019 - Issues related to the role of PBMs in the new structure contemplated by the Act. \n\nHHS rules and regulations related  to the cost of prescription drugs, including, but not limited to,  limiting rebates in the Medicare and Medicaid prescription drug benefits. \n\nLegislative policies and reforms related to Medicare Part B and D specific to the price of prescription medications. \n\nC-THRU Act (S. 476) - Issues related to transparency in the PBM space and ensuring that tools to decrease the cost of prescription medications are maintained.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2019-10-13T09:10:22.420000-04:00"], [2340940, "40b518c7-428a-4ef2-a260-3966f9bc943c", "Q3", "RED+BLUE STRATEGIES", 400693064, "PEW CHARITABLE TRUSTS", 2019, "third_quarter", "MMM", "H.R. 2482 - The Mainstreaming Addiction Treatment Act of 2019 - Support for policies increasing the ability to access MAT to treat addiction. \n\nRegulations promulgated by ONC and HHS related to patient matching, interoperability, unique patient identifiers, unique device identifiers and other HIT tools that can support better patient safety in the Medicare and Medicaid systems.  \n\nIssues related to the implementation on the SUPPORT Act (P.L. 115-271) as they relate to curbing opioid abuse and substance use disorder for Medicare beneficiaries.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2019-10-13T09:20:24.133000-04:00"], [2340942, "276fde68-1270-4d3c-aca8-1df5c8cb2d5a", "Q3", "RED+BLUE STRATEGIES", 400693064, "COMMUNITY CATALYST", 2019, "third_quarter", "MMM", "H.R. 3 - The Lower Drug Costs Act Now Act of 2019 - Issues related to ensuring that prescription medications are affordable to consumers. \n\nH.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 - Issues related to protecting programs regarding spousal impoverishment, money follows the person and ACE Kids.\n\nThe Beneficiary Education Tools, Telehealth, and Extender Reauthorization Act of 2019 (the Better Act) - issues related to quality and beneficiary enrollment. \n\nH.R. 3253 - Empowering Beneficiaries, Ensuring Access and Strengthening Accountability Act of 2019 - Reauthorizing money follows the person and spousal impoverishment programs in the Medicaid program.\n\nIssues related to programs supporting the health of individuals dually eligible for Medicare anf Medicaid.\n\nAdministration guidance and rules regarding Medicaid expansion and work requirements.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2019-10-13T09:25:24.997000-04:00"], [2340944, "3eaa0512-8d85-499c-be70-c0e8700dbc37", "Q3", "RED+BLUE STRATEGIES", 400693064, "DAVITA INC.", 2019, "third_quarter", "MMM", "Administrative actions and demonstrations related coverning care for people with chronic kidney disease and End Stage Renal Disease (ESRD).\n\nLegislative policies related to ensuring that people living with End Stage Renal Disease (ESRD) who are covered through Medicare Fee for Service (FFS) have the supports and services they need.", "HOUSE OF REPRESENTATIVES,SENATE", 70000, null, 0, 0, "2019-10-13T09:31:25.890000-04:00"], [2340990, "17ed0b2e-1506-4a55-999d-45b99acb5233", "Q3", "RED+BLUE STRATEGIES", 400693064, "BLUE CROSS BLUE SHIELD OF MASSACHUSETTS", 2019, "third_quarter", "MMM", "H.R. 3 - Lower Drug Costs Now Act - Issues related to keeping health care costs down for Medicare beneficiaries.\n\nHHS proposed rules related the treatment of rebates in Medicare Part D.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2019-10-13T20:26:51.417000-04:00"], [2340994, "ef2e07b4-dee8-4a4a-a71a-aefb1e39d4b1", "Q3", "RED+BLUE STRATEGIES", 400693064, "AMERICAN SOCIETY FROM RADIATION ONCOLOGY (ASTRO)", 2019, "third_quarter", "MMM", "H.R. 3107 - Issues related to practices regarding prior authorization for certain cancer treatments. \n\nIssues related to CMMI's treatment of proposals for the Radiation Oncology Advance Payment Model (ROAPM)\n\nIssues related to ensuring that cancer patients in rural and underserved communities have access to radiation oncology services if it is part of their treatment plans.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2019-10-13T20:37:53.943000-04:00"], [2340996, "e6cab4c8-7a1a-4c3e-9d8a-effed312664e", "Q3", "RED+BLUE STRATEGIES", 400693064, "BOSTON MEDICAL CENTER", 2019, "third_quarter", "MMM", "H.R. 3 - Lower Drug Costs Now Act - Issues related to the 340(b) program and keeping drugs affordable for lower income Americans.\n\nS. 1895 - Lower Health Care Costs Act - Issues related to surprise billing and transparency.\n\nIssues related to expanding the GME program to allow for additional slots to train physicians in the fight against addiction. \n\nPolicies related to social determinants of health (SDH) with a focus on food as medicine, the importance of stable housing and the need for caregiving supports to help patients to get well and stay well. \n\n\nSupport for the reauthorization of a strong, stable Medicaid DSH program.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2019-10-13T20:41:54.710000-04:00"], [2340997, "28eb5500-73f0-49d3-9086-e13039b6da80", "Q3", "RED+BLUE STRATEGIES", 400693064, "THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA", 2019, "third_quarter", "MMM", "H.R. 3 - Lower Drug Costs Now Act - Issues related to the potential creating of a comprehensive Medicare dental benefit.\n\nIssues related to ensuring quality eye and oral health in the Medicaid program.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2019-10-13T20:49:55.530000-04:00"], [2341000, "d37fd4fe-62ce-4912-8760-5109003d94eb", "Q3", "RED+BLUE STRATEGIES", 400693064, "QUEST DIAGNOSTICS INCORPORATED", 2019, "third_quarter", "MMM", "H.R. 3584 - The LAB Act - focused on issues related to reform of the Protecting Access to Medicare Act (PAMA) with a focus on ensuring that the data collected to set rates is of the highest integrity.", "HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2019-10-13T20:55:56.350000-04:00"]], "truncated": false, "filtered_table_rows_count": 1493, "expanded_columns": [], "expandable_columns": [[{"column": "filing_uuid", "other_table": "lobbying_filings_raw", "other_column": "filing_uuid"}, "registrant_name"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, filing_uuid, filing_type, registrant_name, registrant_id, client_name, filing_year, filing_period, issue_code, specific_issues, government_entities, income_amount, expense_amount, is_no_activity, is_termination, received_date from lobbying_activities where \"filing_period\" = :p0 and \"filing_year\" = :p1 and \"issue_code\" = :p2 order by filing_year desc limit 101", "params": {"p0": "third_quarter", "p1": "2019", "p2": "MMM"}}, "facet_results": {"issue_code": {"name": "issue_code", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2019&issue_code=MMM", "results": [{"value": "MMM", "label": "MMM", "count": 1493, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2019", "selected": true}], "truncated": false}, "filing_year": {"name": "filing_year", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2019&issue_code=MMM", "results": [{"value": 2019, "label": 2019, "count": 1493, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&issue_code=MMM", "selected": true}], "truncated": false}, "filing_period": {"name": "filing_period", "type": "column", "hideable": false, "toggle_url": "/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2019&issue_code=MMM", "results": [{"value": "third_quarter", "label": "third_quarter", "count": 1493, "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_year=2019&issue_code=MMM", "selected": true}], "truncated": false}}, "suggested_facets": [{"name": "filing_type", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2019&issue_code=MMM&_facet=filing_type"}, {"name": "is_termination", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2019&issue_code=MMM&_facet=is_termination"}, {"name": "received_date", "type": "date", "toggle_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2019&issue_code=MMM&_facet_date=received_date"}], "next": "2019,2341000", "next_url": "https://www.pawtectors.org/lobbying/lobbying_activities.json?filing_period=third_quarter&filing_year=2019&issue_code=MMM&_next=2019%2C2341000&_sort_desc=filing_year", "private": false, "allow_execute_sql": true, "query_ms": 2658.603376010433, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}